Literature DB >> 2059077

Heart conduction disturbance: an HLA-B27 associated disease.

A J Peeters1, S ten Wolde, M I Sedney, R R de Vries, B A Dijkmans.   

Abstract

In recent studies from Sweden an increased prevalence of HLA-B27 associated diseases and of HLA-B27 was found in an unselected group of men with permanently implanted pacemakers and with a heart block. Furthermore, a significantly increased prevalence of HLA-B27 was found in men with a pacemaker who had no clinical or radiological signs of HLA-B27 associated disease. To obtain more insight into the association between HLA-B27 and heart block, and the possible role of HLA-B27 in causing this block, a study was made of 35 patients with a pacemaker and heart block of unknown cause, selected from a total group of 350 men with pacemakers who were still alive at the time of the study. One of these 35 men had ankylosing spondylitis and two patients had an asymptomatic sacroiliitis, but all three were HLA-B27 negative. HLA-B27 was present in five (14%) patients, which is a significantly higher prevalence than in healthy controls (17/292, 6%). This percentage is equal to the percentage of HLA-B27 positivity found in the Swedish study on unselected men with an implanted pacemaker, in whom the presence of an HLA-B27 associated disease had been excluded. It suggests that factors other than HLA-B27 are important in the pathogenesis of heart block in most patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059077      PMCID: PMC1004433          DOI: 10.1136/ard.50.6.348

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  New views on B27 associated diseases.

Authors:  T E Feltkamp
Journal:  Neth J Med       Date:  1989-10       Impact factor: 1.422

2.  Letter: Normal frequency of HL-A B27 in aortic insufficiency.

Authors:  A Calin; J F Fries; E B Stinson; R Payne
Journal:  N Engl J Med       Date:  1976-02-12       Impact factor: 91.245

3.  Ambulatory 24-hour continuous electrocardiographic monitoring in 54 patients with ankylosing spondylitis.

Authors:  N H Thomsen; K Hørslev-Petersen; J M Beyer
Journal:  Eur Heart J       Date:  1986-03       Impact factor: 29.983

4.  Cardiovascular manifestations of ankylosing spondylitis.

Authors:  T D Kinsella; L G Johnson; R Ian
Journal:  Can Med Assoc J       Date:  1974-12-21       Impact factor: 8.262

5.  Cardiac conduction disturbances, an underestimated manifestation in ankylosing spondylitis. A 25-year follow-up study of 68 patients.

Authors:  L Bergfeldt; O Edhag; H Vallin
Journal:  Acta Med Scand       Date:  1982

6.  Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker-treated men.

Authors:  L Bergfeldt; O Edhag; L Vedin; H Vallin
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

7.  The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study.

Authors:  D A Brewerton; D G Gibson; D H Goddard; T J Jones; R B Moore; C T Pease; P A Revell; L M Shapiro; K V Swettenham
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

8.  HLA B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakers.

Authors:  L Bergfeldt
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

9.  Seronegative spondyloarthropathies in lone aortic insufficiency.

Authors:  S Qaiyumi; Z U Hassan; E Toone
Journal:  Arch Intern Med       Date:  1985-05

10.  Complete heart block--another HLA B27 associated disease manifestation.

Authors:  L Bergfeldt; E Möller
Journal:  Tissue Antigens       Date:  1983-05
View more
  7 in total

1.  Third-degree heart block developing in a female patient with HLA-B27 positive ankylosing spondylitis.

Authors:  Vasfi Ulusoy; Aşkin Ateş; Hülya Ciçekcioğlu; Yonca Avcioğlu; Yaşar Karaaslan
Journal:  Rheumatol Int       Date:  2005-10-20       Impact factor: 2.631

Review 2.  Axial spondyloarthritis: the heart of the matter.

Authors:  Lianne S Gensler
Journal:  Clin Rheumatol       Date:  2015-05-10       Impact factor: 2.980

3.  Frequency of fragmented QRS in ankylosing spondylitis : a prospective controlled study.

Authors:  A Inanir; K Ceyhan; S Okan; H Kadi
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

4.  Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring.

Authors:  Mustafa Candemir; Burcu Candemir; Adem Ertürk
Journal:  Clin Rheumatol       Date:  2020-03-25       Impact factor: 2.980

Review 5.  Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.

Authors:  Michael T Nurmohamed; Irene van der Horst-Bruinsma; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

6.  Ankylosing Spondylitis and Risk of Cardiac Arrhythmia and Conduction Disorders: A Systematic Review and Meta-analysis.

Authors:  Negar Morovatdar; Gerald F Watts; Yones Bondarsahebi; Fatemeh Goldani; Elham Rahmanipour; Ramin Rezaee; Amirhossein Sahebkar
Journal:  Curr Cardiol Rev       Date:  2021

7.  Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study.

Authors:  Karin Bengtsson; Eva Klingberg; Anna Deminger; Hanna Wallberg; Lennart T H Jacobsson; Lennart Bergfeldt; Helena Forsblad-d'Elia
Journal:  RMD Open       Date:  2019-11-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.